{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:12:33Z","timestamp":1789499553074,"version":"build-2803163510"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071511"],"award-info":[{"award-number":["82071511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12035-024-04239-9","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:01:55Z","timestamp":1716436915000},"page":"10722-10735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances on the Mechanisms and Therapeutic Strategies in Non-coding CGG Repeat Expansion Diseases"],"prefix":"10.1007","volume":"61","author":[{"given":"Yutong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0205-6342","authenticated-orcid":false,"given":"Xingshun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"1","key":"4239_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13059-019-1667-6","volume":"20","author":"S Mitsuhashi","year":"2019","unstructured":"Mitsuhashi S et al (2019) Tandem-genotypes: robust detection of tandem repeat expansions from long DNA reads. Genome Biol 20(1):58","journal-title":"Genome Biol"},{"key":"4239_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","volume":"147","author":"H Paulson","year":"2018","unstructured":"Paulson H (2018) Repeat expansion diseases. Handb Clin Neurol 147:105\u2013123","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"4239_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12035-019-01724-4","volume":"57","author":"AK Verma","year":"2020","unstructured":"Verma AK et al (2020) Exploring the potential of small molecule-based therapeutic approaches for Targeting Trinucleotide repeat disorders. Mol Neurobiol 57(1):566\u2013584","journal-title":"Mol Neurobiol"},{"key":"4239_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-biochem-060614-034010","volume":"84","author":"RR Iyer","year":"2015","unstructured":"Iyer RR et al (2015) DNA triplet repeat expansion and mismatch repair. Annu Rev Biochem 84:199\u2013226","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"4239_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","volume":"84","author":"SC Warby","year":"2009","unstructured":"Warby SC et al (2009) CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 84(3):351\u2013366","journal-title":"Am J Hum Genet"},{"key":"4239_CR6","doi-asserted-by":"crossref","unstructured":"Thornton CA (2014) Myotonic dystrophy. Neurol Clin, 32(3): p. 705\u2009\u2013\u200919, viii.","DOI":"10.1016\/j.ncl.2014.04.011"},{"issue":"6","key":"4239_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ajmg.b.30910","volume":"150b","author":"JR Brouwer","year":"2009","unstructured":"Brouwer JR, Willemsen R, Oostra BA (2009) The FMR1 gene and fragile X-associated tremor\/ataxia syndrome. Am J Med Genet B Neuropsychiatr Genet 150b(6):782\u2013798","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"4239_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-62703-411-1_1","volume":"1010","author":"H Budworth","year":"2013","unstructured":"Budworth H, McMurray CT (2013) A brief history of triplet repeat diseases. Methods Mol Biol 1010:3\u201317","journal-title":"Methods Mol Biol"},{"issue":"5","key":"4239_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","volume":"108","author":"C Depienne","year":"2021","unstructured":"Depienne C, Mandel JL (2021) 30 years of repeat expansion disorders: what have we learned and what are the remaining challenges? Am J Hum Genet 108(5):764\u2013785","journal-title":"Am J Hum Genet"},{"issue":"8","key":"4239_CR10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/s41588-019-0458-z","volume":"51","author":"H Ishiura","year":"2019","unstructured":"Ishiura H et al (2019) Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet 51(8):1222\u20131232","journal-title":"Nat Genet"},{"issue":"2","key":"4239_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/archneur.1977.00500140043007","volume":"34","author":"E Satoyoshi","year":"1977","unstructured":"Satoyoshi E, Kinoshita M (1977) Oculopharyngodistal myopathy. Arch Neurol 34(2):89\u201392","journal-title":"Arch Neurol"},{"issue":"3","key":"4239_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s10038-022-01116-y","volume":"68","author":"H Ishiura","year":"2023","unstructured":"Ishiura H, Tsuji S, Toda T (2023) Recent advances in CGG repeat diseases and a proposal of fragile X-associated tremor\/ataxia syndrome, neuronal intranuclear inclusion disease, and oculophryngodistal myopathy (FNOP) spectrum disorder. J Hum Genet 68(3):169\u2013174","journal-title":"J Hum Genet"},{"issue":"1","key":"4239_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40478-020-01084-4","volume":"8","author":"M Ogasawara","year":"2020","unstructured":"Ogasawara M et al (2020) CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun 8(1):204","journal-title":"Acta Neuropathol Commun"},{"key":"4239_CR14","doi-asserted-by":"crossref","unstructured":"Macpherson JN, Murray A (2016) Development of genetic testing for Fragile X Syndrome and Associated disorders, and estimates of the prevalence of FMR1 expansion mutations. Genes (Basel), 7(12)","DOI":"10.3390\/genes7120110"},{"key":"4239_CR15","doi-asserted-by":"crossref","unstructured":"Kshatri A et al (2020) Differential regulation of BK channels by fragile X mental retardation protein. J Gen Physiol, 152(6)","DOI":"10.1085\/jgp.201912502"},{"issue":"6","key":"4239_CR16","doi-asserted-by":"publisher","first-page":"R273","DOI":"10.1016\/j.cub.2021.01.043","volume":"31","author":"PJ Hagerman","year":"2021","unstructured":"Hagerman PJ, Hagerman R (2021) Fragile X syndrome. Curr Biol 31(6):R273\u2013r275","journal-title":"Curr Biol"},{"key":"4239_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fgene.2018.00442","volume":"9","author":"E Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez E et al (2018) FXS-Like phenotype in two unrelated patients carrying a methylated premutation of the FMR1 gene. Front Genet 9:442","journal-title":"Front Genet"},{"issue":"1","key":"4239_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13052-017-0355-y","volume":"43","author":"C Ciaccio","year":"2017","unstructured":"Ciaccio C et al (2017) Fragile X syndrome: a review of clinical and molecular diagnoses. Ital J Pediatr 43(1):39","journal-title":"Ital J Pediatr"},{"issue":"2","key":"4239_CR19","first-page":"e21840","volume":"14","author":"M Davidson","year":"2022","unstructured":"Davidson M et al (2022) Behavioral problems in Fragile X syndrome: a review of Clinical Management. Cureus 14(2):e21840","journal-title":"Cureus"},{"issue":"6","key":"4239_CR20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ejhg.2008.61","volume":"16","author":"KB Garber","year":"2008","unstructured":"Garber KB, Visootsak J, Warren ST (2008) Fragile X syndrome. Eur J Hum Genet 16(6):666\u2013672","journal-title":"Eur J Hum Genet"},{"key":"4239_CR21","unstructured":"Stone WL et al (2023) Fragile X syndrome, in StatPearls. StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Hajira Basit declares no relevant financial relationships with ineligible companies. Disclosure: Manan Shah declares no relevant financial relationships with ineligible companies. Disclosure: Evan Los declares no relevant financial relationships with ineligible companies"},{"issue":"8","key":"4239_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1176\/appi.ajp.21090896","volume":"179","author":"MD Shen","year":"2022","unstructured":"Shen MD et al (2022) Subcortical Brain Development in Autism and Fragile X Syndrome: evidence for dynamic, age- and disorder-specific trajectories in Infancy. Am J Psychiatry 179(8):562\u2013572","journal-title":"Am J Psychiatry"},{"issue":"11","key":"4239_CR23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamapsychiatry.2013.247","volume":"70","author":"SS Hall","year":"2013","unstructured":"Hall SS et al (2013) Identifying large-scale brain networks in fragile X syndrome. JAMA Psychiatry 70(11):1215\u20131223","journal-title":"JAMA Psychiatry"},{"key":"4239_CR24","doi-asserted-by":"crossref","unstructured":"Cabal-Herrera AM et al (2020) Fragile X-Associated Tremor\/Ataxia syndrome (FXTAS): pathophysiology and clinical implications. Int J Mol Sci, 21(12)","DOI":"10.3390\/ijms21124391"},{"issue":"2","key":"4239_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ncpneuro0373","volume":"3","author":"PJ Hagerman","year":"2007","unstructured":"Hagerman PJ, Hagerman RJ (2007) Fragile X-associated tremor\/ataxia syndrome\u2013an older face of the fragile X gene. Nat Clin Pract Neurol 3(2):107\u2013112","journal-title":"Nat Clin Pract Neurol"},{"issue":"12","key":"4239_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/gm401","volume":"4","author":"F Tassone","year":"2012","unstructured":"Tassone F et al (2012) FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4(12):100","journal-title":"Genome Med"},{"issue":"4","key":"4239_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/374321","volume":"72","author":"S Jacquemont","year":"2003","unstructured":"Jacquemont S et al (2003) Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72(4):869\u2013878","journal-title":"Am J Hum Genet"},{"issue":"4","key":"4239_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neurol.2020.08.008","volume":"177","author":"A Lapostolle","year":"2021","unstructured":"Lapostolle A et al (2021) FXTAS patient presenting as Huntington-like generalized chorea. Rev Neurol (Paris) 177(4):445\u2013446","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"4239_CR29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1086\/420700","volume":"74","author":"RJ Hagerman","year":"2004","unstructured":"Hagerman RJ et al (2004) Fragile-X-associated tremor\/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74(5):1051\u20131056","journal-title":"Am J Hum Genet"},{"issue":"4","key":"4239_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","volume":"291","author":"S Jacquemont","year":"2004","unstructured":"Jacquemont S et al (2004) Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population. JAMA 291(4):460\u2013469","journal-title":"JAMA"},{"issue":"Pt 8","key":"4239_CR31","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/brain\/awf184","volume":"125","author":"CM Greco","year":"2002","unstructured":"Greco CM et al (2002) Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers. Brain 125(Pt 8):1760\u20131771","journal-title":"Brain"},{"issue":"1","key":"4239_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-013-1138-1","volume":"126","author":"P Hagerman","year":"2013","unstructured":"Hagerman P (2013) Fragile X-associated tremor\/ataxia syndrome (FXTAS): pathology and mechanisms. Acta Neuropathol 126(1):1\u201319","journal-title":"Acta Neuropathol"},{"issue":"9","key":"4239_CR33","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1007\/s12035-016-0194-7","volume":"54","author":"MI Alvarez-Mora","year":"2017","unstructured":"Alvarez-Mora MI et al (2017) Impaired mitochondrial function and Dynamics in the pathogenesis of FXTAS. Mol Neurobiol 54(9):6896\u20136902","journal-title":"Mol Neurobiol"},{"key":"4239_CR34","doi-asserted-by":"crossref","unstructured":"Dufour BD et al (2023) FXTAS neuropathology includes widespread reactive astrogliosis and white matter specific astrocyte degeneration Ann Neurol","DOI":"10.1002\/ana.26851"},{"issue":"18","key":"4239_CR35","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","volume":"79","author":"E Apartis","year":"2012","unstructured":"Apartis E et al (2012) FXTAS: new insights and the need for revised diagnostic criteria. Neurology 79(18):1898\u20131907","journal-title":"Neurology"},{"issue":"Pt 1","key":"4239_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/brain\/awh683","volume":"129","author":"CM Greco","year":"2006","unstructured":"Greco CM et al (2006) Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS). Brain 129(Pt 1):243\u2013255","journal-title":"Brain"},{"key":"4239_CR37","doi-asserted-by":"publisher","first-page":"720253","DOI":"10.3389\/fnins.2021.720253","volume":"15","author":"MJ Salcedo-Arellano","year":"2021","unstructured":"Salcedo-Arellano MJ et al (2021) Case Report: coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome. Front Neurosci 15:720253","journal-title":"Front Neurosci"},{"issue":"9","key":"4239_CR38","doi-asserted-by":"publisher","first-page":"E100","DOI":"10.3174\/ajnr.A5729","volume":"39","author":"IG Padilha","year":"2018","unstructured":"Padilha IG et al (2018) MR Imaging features of adult-onset neuronal intranuclear inclusion Disease May be indistinguishable from Fragile X-Associated Tremor\/Ataxia Syndrome. AJNR Am J Neuroradiol 39(9):E100\u2013e101","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"4239_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11604-022-01343-5","volume":"41","author":"R Kurokawa","year":"2023","unstructured":"Kurokawa R et al (2023) Clinical and neuroimaging review of triplet repeat diseases. Jpn J Radiol 41(2):115\u2013130","journal-title":"Jpn J Radiol"},{"issue":"2","key":"4239_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.nmd.2010.10.002","volume":"21","author":"W Thevathasan","year":"2011","unstructured":"Thevathasan W et al (2011) Oculopharyngodistal myopathy\u2013a possible association with cardiomyopathy. Neuromuscul Disord 21(2):121\u2013125","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"4239_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/jamaneurol.2021.1509","volume":"78","author":"T Kumutpongpanich","year":"2021","unstructured":"Kumutpongpanich T et al (2021) Clinicopathologic features of Oculopharyngodistal Myopathy with LRP12 CGG repeat expansions compared with other Oculopharyngodistal Myopathy subtypes. JAMA Neurol 78(7):853\u2013863","journal-title":"JAMA Neurol"},{"issue":"8","key":"4239_CR42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mus.880180807","volume":"18","author":"AA Amato","year":"1995","unstructured":"Amato AA et al (1995) Childhood-onset oculopharyngodistal myopathy with chronic intestinal pseudo-obstruction. Muscle Nerve 18(8):842\u2013847","journal-title":"Muscle Nerve"},{"issue":"3","key":"4239_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/WNL.0b013e318207b043","volume":"76","author":"H Durmus","year":"2011","unstructured":"Durmus H et al (2011) Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients. Neurology 76(3):227\u2013235","journal-title":"Neurology"},{"issue":"3","key":"4239_CR44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ajhg.2022.01.012","volume":"109","author":"J Yu","year":"2022","unstructured":"Yu J et al (2022) The CGG repeat expansion in RILPL1 is associated with oculopharyngodistal myopathy type 4. Am J Hum Genet 109(3):533\u2013541","journal-title":"Am J Hum Genet"},{"issue":"6","key":"4239_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1440-1789.2008.00924.x","volume":"28","author":"H Lu","year":"2008","unstructured":"Lu H et al (2008) The clinical and myopathological features of oculopharyngodistal myopathy in a Chinese family. Neuropathology 28(6):599\u2013603","journal-title":"Neuropathology"},{"issue":"6","key":"4239_CR46","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/acn3.51371","volume":"8","author":"J Yu","year":"2021","unstructured":"Yu J et al (2021) GGC repeat expansions in NOTCH2NLC causing a phenotype of distal motor neuropathy and myopathy. Ann Clin Transl Neurol 8(6):1330\u20131342","journal-title":"Ann Clin Transl Neurol"},{"key":"4239_CR47","doi-asserted-by":"crossref","unstructured":"Zeng YH et al (2022) GGC repeat expansion of RILPL1 is associated with oculopharyngodistal myopathy Ann Neurol","DOI":"10.1002\/ana.26436"},{"issue":"6","key":"4239_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ajhg.2020.04.011","volume":"106","author":"J Deng","year":"2020","unstructured":"Deng J et al (2020) Expansion of GGC repeat in GIPC1 is Associated with Oculopharyngodistal Myopathy. Am J Hum Genet 106(6):793\u2013804","journal-title":"Am J Hum Genet"},{"key":"4239_CR49","doi-asserted-by":"crossref","unstructured":"Gu X et al (2023) Non-coding CGG repeat expansion in LOC642361\/NUTM2B-AS1 is associated with a phenotype of oculopharyngodistal myopathy. J Med Genet","DOI":"10.1136\/jmg-2023-109345"},{"issue":"12","key":"4239_CR50","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1007\/s00415-023-11906-9","volume":"270","author":"N Eura","year":"2023","unstructured":"Eura N et al (2023) Characteristics of the muscle involvement along the disease progression in a large cohort of oculopharyngodistal myopathy compared to oculopharyngeal muscular dystrophy. J Neurol 270(12):5988\u20135998","journal-title":"J Neurol"},{"key":"4239_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mcn.2012.12.006","volume":"56","author":"VV Belzil","year":"2013","unstructured":"Belzil VV, Gendron TF, Petrucelli L (2013) RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci 56:406\u2013419","journal-title":"Mol Cell Neurosci"},{"key":"4239_CR52","doi-asserted-by":"crossref","unstructured":"Glineburg MR et al (2018) Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in fragile X tremor ataxia syndrome Brain Res, 1693(Pt A): pp. 43\u201354","DOI":"10.1016\/j.brainres.2018.02.006"},{"issue":"2","key":"4239_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1042\/BST20200690","volume":"49","author":"LM Castelli","year":"2021","unstructured":"Castelli LM et al (2021) Mechanisms of repeat-associated non-AUG translation in neurological microsatellite expansion disorders. Biochem Soc Trans 49(2):775\u2013792","journal-title":"Biochem Soc Trans"},{"key":"4239_CR54","doi-asserted-by":"publisher","first-page":"843014","DOI":"10.3389\/fgene.2022.843014","volume":"13","author":"M Boivin","year":"2022","unstructured":"Boivin M, Charlet-Berguerand N (2022) Trinucleotide CGG repeat diseases: an Expanding Field of Polyglycine Proteins? Front Genet 13:843014","journal-title":"Front Genet"},{"issue":"3","key":"4239_CR55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","volume":"78","author":"PK Todd","year":"2013","unstructured":"Todd PK et al (2013) CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78(3):440\u2013455","journal-title":"Neuron"},{"issue":"41","key":"4239_CR56","doi-asserted-by":"publisher","first-page":"e2208649119","DOI":"10.1073\/pnas.2208649119","volume":"119","author":"J Yu","year":"2022","unstructured":"Yu J et al (2022) CGG repeat expansion in NOTCH2NLC causes mitochondrial dysfunction and progressive neurodegeneration in Drosophila model. Proc Natl Acad Sci U S A 119(41):e2208649119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4239_CR57","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-Bejarano A et al (2023) Mitochondrial dysfunction in repeat expansion diseases. Antioxid (Basel), 12(8)","DOI":"10.3390\/antiox12081593"},{"issue":"23","key":"4239_CR58","doi-asserted-by":"publisher","first-page":"e2300052120","DOI":"10.1073\/pnas.2300052120","volume":"120","author":"CM Dias","year":"2023","unstructured":"Dias CM et al (2023) Glial dysregulation in the human brain in fragile X-associated tremor\/ataxia syndrome. Proc Natl Acad Sci U S A 120(23):e2300052120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4239_CR59","doi-asserted-by":"crossref","unstructured":"Tabolacci E et al (2022) Mechanisms of the FMR1 repeat instability: how does the CGG sequence expand? Int J Mol Sci, 23(10)","DOI":"10.3390\/ijms23105425"},{"issue":"15","key":"4239_CR60","doi-asserted-by":"publisher","first-page":"10196","DOI":"10.1093\/nar\/gku710","volume":"42","author":"M Malgowska","year":"2014","unstructured":"Malgowska M et al (2014) Distinctive structural motifs of RNA G-quadruplexes composed of AGG, CGG and UGG trinucleotide repeats. Nucleic Acids Res 42(15):10196\u201310207","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4239_CR61","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/nar\/gkr836","volume":"40","author":"RP Anand","year":"2012","unstructured":"Anand RP et al (2012) Overcoming natural replication barriers: differential helicase requirements. Nucleic Acids Res 40(3):1091\u20131105","journal-title":"Nucleic Acids Res"},{"key":"4239_CR62","doi-asserted-by":"crossref","unstructured":"Teng Y, Zhu M, Qiu Z (2023) G-Quadruplexes in repeat expansion disorders. Int J Mol Sci, 24(3)","DOI":"10.3390\/ijms24032375"},{"issue":"5","key":"4239_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/gcc.22721","volume":"58","author":"S Kaushal","year":"2019","unstructured":"Kaushal S, Freudenreich CH (2019) The role of fork stalling and DNA structures in causing chromosome fragility. Genes Chromosomes Cancer 58(5):270\u2013283","journal-title":"Genes Chromosomes Cancer"},{"issue":"20","key":"4239_CR64","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1101\/gad.288142.116","volume":"30","author":"JL Alexander","year":"2016","unstructured":"Alexander JL, Orr-Weaver TL (2016) Replication fork instability and the consequences of fork collisions from rereplication. Genes Dev 30(20):2241\u20132252","journal-title":"Genes Dev"},{"issue":"4","key":"4239_CR65","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/10409238.2017.1314444","volume":"52","author":"CJ Sakofsky","year":"2017","unstructured":"Sakofsky CJ, Malkova A (2017) Break induced replication in eukaryotes: mechanisms, functions, and consequences. Crit Rev Biochem Mol Biol 52(4):395\u2013413","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"8","key":"4239_CR66","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41594-018-0094-9","volume":"25","author":"AV Kononenko","year":"2018","unstructured":"Kononenko AV et al (2018) Mechanisms of genetic instability caused by (CGG)(n) repeats in an experimental mammalian system. Nat Struct Mol Biol 25(8):669\u2013676","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"4239_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/10409238.2014.999192","volume":"50","author":"K Usdin","year":"2015","unstructured":"Usdin K, House NC, Freudenreich CH (2015) Repeat instability during DNA repair: insights from model systems. Crit Rev Biochem Mol Biol 50(2):142\u2013167","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"4","key":"4239_CR68","doi-asserted-by":"publisher","first-page":"e1004294","DOI":"10.1371\/journal.pgen.1004294","volume":"10","author":"EW Loomis","year":"2014","unstructured":"Loomis EW et al (2014) Transcription-associated R-loop formation across the human FMR1 CGG-repeat region. PLoS Genet 10(4):e1004294","journal-title":"PLoS Genet"},{"issue":"1","key":"4239_CR69","doi-asserted-by":"publisher","first-page":"e101112","DOI":"10.15252\/embj.2018101112","volume":"39","author":"B Swinnen","year":"2020","unstructured":"Swinnen B, Robberecht W, Van Den Bosch L (2020) RNA toxicity in non-coding repeat expansion disorders. Embo j 39(1):e101112","journal-title":"Embo j"},{"issue":"1","key":"4239_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/10409238.2020.1841726","volume":"56","author":"JL Schwartz","year":"2021","unstructured":"Schwartz JL, Jones KL, Yeo GW (2021) Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies. Crit Rev Biochem Mol Biol 56(1):31\u201353","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"4239_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40478-021-01169-8","volume":"9","author":"MR Glineburg","year":"2021","unstructured":"Glineburg MR et al (2021) Enhanced detection of expanded repeat mRNA foci with hybridization chain reaction. Acta Neuropathol Commun 9(1):73","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4239_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/WNL.57.1.127","volume":"57","author":"RJ Hagerman","year":"2001","unstructured":"Hagerman RJ et al (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57(1):127\u2013130","journal-title":"Neurology"},{"key":"4239_CR73","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.nbd.2020.104740","volume":"136","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ et al (2020) Fragile X syndrome and associated disorders: clinical aspects and pathology. Neurobiol Dis 136:104740","journal-title":"Neurobiol Dis"},{"issue":"5","key":"4239_CR74","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12311-016-0797-6","volume":"15","author":"M Foote","year":"2016","unstructured":"Foote M et al (2016) Fragile X-Associated Tremor\/Ataxia syndrome (FXTAS) Motor Dysfunction Modeled in mice. Cerebellum 15(5):611\u2013622","journal-title":"Cerebellum"},{"issue":"5","key":"4239_CR75","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0896-6273(03)00533-6","volume":"39","author":"P Jin","year":"2003","unstructured":"Jin P et al (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39(5):739\u2013747","journal-title":"Neuron"},{"issue":"Pt 1","key":"4239_CR76","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/brain\/awh650","volume":"129","author":"CK Iwahashi","year":"2006","unstructured":"Iwahashi CK et al (2006) Protein composition of the intranuclear inclusions of FXTAS. Brain 129(Pt 1):256\u2013271","journal-title":"Brain"},{"issue":"2","key":"4239_CR77","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2019.03.014","volume":"102","author":"JK Nussbacher","year":"2019","unstructured":"Nussbacher JK et al (2019) Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron 102(2):294\u2013320","journal-title":"Neuron"},{"issue":"3","key":"4239_CR78","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.celrep.2013.02.004","volume":"3","author":"C Sellier","year":"2013","unstructured":"Sellier C et al (2013) Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor\/ataxia syndrome. Cell Rep 3(3):869\u2013880","journal-title":"Cell Rep"},{"issue":"4","key":"4239_CR79","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neuron.2007.07.021","volume":"55","author":"OA Sofola","year":"2007","unstructured":"Sofola OA et al (2007) RNA-binding proteins hnRNP A2\/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55(4):565\u2013571","journal-title":"Neuron"},{"issue":"7","key":"4239_CR80","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/emboj.2010.21","volume":"29","author":"C Sellier","year":"2010","unstructured":"Sellier C et al (2010) Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. Embo j 29(7):1248\u20131261","journal-title":"Embo j"},{"issue":"2","key":"4239_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4161\/rna.1.2.1035","volume":"1","author":"F Tassone","year":"2004","unstructured":"Tassone F, Iwahashi C, Hagerman PJ (2004) FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor\/ataxia syndrome (FXTAS). RNA Biol 1(2):103\u2013105","journal-title":"RNA Biol"},{"key":"4239_CR82","doi-asserted-by":"publisher","first-page":"e08881","DOI":"10.7554\/eLife.08881","volume":"4","author":"AS Burguete","year":"2015","unstructured":"Burguete AS et al (2015) GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. Elife 4:e08881","journal-title":"Elife"},{"issue":"4","key":"4239_CR83","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neuron.2007.07.020","volume":"55","author":"P Jin","year":"2007","unstructured":"Jin P et al (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor\/ataxia syndrome. Neuron 55(4):556\u2013564","journal-title":"Neuron"},{"issue":"3","key":"4239_CR84","doi-asserted-by":"publisher","first-page":"e1002018","DOI":"10.1371\/journal.pgen.1002018","volume":"7","author":"CE Pearson","year":"2011","unstructured":"Pearson CE (2011) Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities! PLoS Genet 7(3):e1002018","journal-title":"PLoS Genet"},{"issue":"2","key":"4239_CR85","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.molcel.2016.02.034","volume":"62","author":"MG Kearse","year":"2016","unstructured":"Kearse MG et al (2016) CGG repeat-Associated Non-AUG Translation utilizes a Cap-Dependent scanning mechanism of initiation to produce toxic proteins. Mol Cell 62(2):314\u2013322","journal-title":"Mol Cell"},{"key":"4239_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2016.04.003","volume":"1647","author":"KM Green","year":"2016","unstructured":"Green KM, Linsalata AE, Todd PK (2016) RAN translation-what makes it run? Brain Res 1647:30\u201342","journal-title":"Brain Res"},{"issue":"15","key":"4239_CR87","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1093\/nar\/gkac626","volume":"50","author":"SE Wright","year":"2022","unstructured":"Wright SE et al (2022) CGG repeats trigger translational frameshifts that generate aggregation-prone chimeric proteins. Nucleic Acids Res 50(15):8674\u20138689","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4239_CR88","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuron.2016.12.016","volume":"93","author":"C Sellier","year":"2017","unstructured":"Sellier C et al (2017) Translation of expanded CGG repeats into FMRpolyG is pathogenic and may contribute to Fragile X Tremor Ataxia Syndrome. Neuron 93(2):331\u2013347","journal-title":"Neuron"},{"key":"4239_CR89","doi-asserted-by":"crossref","unstructured":"Asamitsu S et al (2021) CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor\/ataxia syndrome. Sci Adv, 7(3)","DOI":"10.1126\/sciadv.abd9440"},{"key":"4239_CR90","doi-asserted-by":"crossref","unstructured":"Nguyen XP et al (2022) Expression of FMRpolyG in peripheral blood mononuclear cells of women with fragile X mental retardation 1 gene premutation, vol 13. Genes (Basel)","DOI":"10.3390\/genes13030451"},{"issue":"1","key":"4239_CR91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s40478-019-0796-1","volume":"7","author":"L Ma","year":"2019","unstructured":"Ma L et al (2019) Composition of the Intranuclear inclusions of Fragile X-associated Tremor\/Ataxia Syndrome. Acta Neuropathol Commun 7(1):143","journal-title":"Acta Neuropathol Commun"},{"key":"4239_CR92","doi-asserted-by":"publisher","first-page":"106212","DOI":"10.1016\/j.nbd.2023.106212","volume":"184","author":"I Malik","year":"2023","unstructured":"Malik I et al (2023) Dissecting the roles of EIF4G homologs reveals DAP5 as a modifier of CGG repeat-associated toxicity in a Drosophila model of FXTAS. Neurobiol Dis 184:106212","journal-title":"Neurobiol Dis"},{"issue":"9","key":"4239_CR93","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41580-021-00382-6","volume":"22","author":"I Malik","year":"2021","unstructured":"Malik I et al (2021) Molecular mechanisms underlying nucleotide repeat expansion disorders. Nat Rev Mol Cell Biol 22(9):589\u2013607","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"4239_CR94","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.neuron.2021.03.038","volume":"109","author":"M Boivin","year":"2021","unstructured":"Boivin M et al (2021) Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: the polyG diseases. Neuron 109(11):1825\u20131835e5","journal-title":"Neuron"},{"key":"4239_CR95","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fgene.2019.00249","volume":"10","author":"G Hoem","year":"2019","unstructured":"Hoem G et al (2019) The FMRpolyGlycine protein mediates aggregate formation and toxicity Independent of the CGG mRNA hairpin in a Cellular Model for FXTAS. Front Genet 10:249","journal-title":"Front Genet"},{"issue":"5","key":"4239_CR96","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/WCO.0000000000001089","volume":"35","author":"J Yu","year":"2022","unstructured":"Yu J, Deng J, Wang Z (2022) Oculopharyngodistal myopathy. Curr Opin Neurol 35(5):637\u2013644","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"4239_CR97","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-019-0782-7","volume":"7","author":"A Krans","year":"2019","unstructured":"Krans A et al (2019) Neuropathology of RAN translation proteins in fragile X-associated tremor\/ataxia syndrome. Acta Neuropathol Commun 7(1):152","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4239_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","volume":"23","author":"M Golpich","year":"2017","unstructured":"Golpich M et al (2017) Mitochondrial dysfunction and Biogenesis in neurodegenerative diseases: Pathogenesis and treatment. CNS Neurosci Ther 23(1):5\u201322","journal-title":"CNS Neurosci Ther"},{"key":"4239_CR99","doi-asserted-by":"crossref","unstructured":"Zafarullah M et al (2023) Blood proteome profiling reveals biomarkers and pathway alterations in Fragile X PM at risk for developing FXTAS. Int J Mol Sci, 24(17)","DOI":"10.3390\/ijms241713477"},{"issue":"6","key":"4239_CR100","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.bbadis.2019.02.010","volume":"1865","author":"D Gohel","year":"2019","unstructured":"Gohel D et al (2019) FMRpolyG alters mitochondrial transcripts level and respiratory chain complex assembly in Fragile X associated tremor\/ataxia syndrome [FXTAS]. Biochim Biophys Acta Mol Basis Dis 1865(6):1379\u20131388","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"4239_CR101","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/BJ20091960","volume":"429","author":"C Ross-Inta","year":"2010","unstructured":"Ross-Inta C et al (2010) Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome. Biochem J 429(3):545\u2013552","journal-title":"Biochem J"},{"issue":"12","key":"4239_CR102","doi-asserted-by":"publisher","first-page":"165918","DOI":"10.1016\/j.bbadis.2020.165918","volume":"1866","author":"D Gohel","year":"2020","unstructured":"Gohel D et al (2020) The emerging molecular mechanisms for mitochondrial dysfunctions in FXTAS. Biochim Biophys Acta Mol Basis Dis 1866(12):165918","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"4239_CR103","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00439-019-02104-7","volume":"139","author":"V Nobile","year":"2020","unstructured":"Nobile V et al (2020) Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene. Hum Genet 139(2):227\u2013245","journal-title":"Hum Genet"},{"issue":"2","key":"4239_CR104","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","volume":"154","author":"L Mouchiroud","year":"2013","unstructured":"Mouchiroud L et al (2013) The NAD(+)\/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO Signaling. Cell 154(2):430\u2013441","journal-title":"Cell"},{"key":"4239_CR105","doi-asserted-by":"publisher","first-page":"762915","DOI":"10.3389\/fpsyt.2021.762915","volume":"12","author":"D Johnson","year":"2021","unstructured":"Johnson D et al (2021) Increased Pain Symptomatology among females vs. males with fragile X-Associated Tremor\/Ataxia syndrome. Front Psychiatry 12:762915","journal-title":"Front Psychiatry"},{"issue":"8","key":"4239_CR106","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1074\/jbc.M111.301366","volume":"287","author":"V Kumar","year":"2012","unstructured":"Kumar V et al (2012) Activation of intracellular metabotropic glutamate receptor 5 in striatal neurons leads to up-regulation of genes associated with sustained synaptic transmission including Arc\/Arg3.1 protein. J Biol Chem 287(8):5412\u20135425","journal-title":"J Biol Chem"},{"key":"4239_CR107","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neulet.2015.10.037","volume":"609","author":"JK Choi","year":"2015","unstructured":"Choi JK et al (2015) Combined behavioral studies and in vivo imaging of inflammatory response and expression of mGlu5 receptors in schnurri-2 knockout mice. Neurosci Lett 609:159\u2013164","journal-title":"Neurosci Lett"},{"key":"4239_CR108","doi-asserted-by":"crossref","unstructured":"Dahl V et al (2022) Characterization of a mGluR5 knockout rat model with Hallmarks of Fragile X Syndrome. Life (Basel), 12(9).","DOI":"10.3390\/life12091308"},{"key":"4239_CR109","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1742-2094-11-110","volume":"11","author":"M Careaga","year":"2014","unstructured":"Careaga M et al (2014) Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation 11:110","journal-title":"J Neuroinflammation"},{"key":"4239_CR110","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1742-2094-9-238","volume":"9","author":"D Marek","year":"2012","unstructured":"Marek D et al (2012) Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10. J Neuroinflammation 9:238","journal-title":"J Neuroinflammation"},{"key":"4239_CR111","doi-asserted-by":"crossref","unstructured":"Salcedo-Arellano MJ et al (2023) Brain metabolomics in Fragile X-Associated Tremor\/Ataxia Syndrome (FXTAS). Cells, 12(17)","DOI":"10.3390\/cells12172132"},{"key":"4239_CR112","doi-asserted-by":"crossref","unstructured":"Zuo L et al (2019) Inflammaging and oxidative stress in Human diseases: from Molecular mechanisms to Novel treatments. Int J Mol Sci, 20(18)","DOI":"10.3390\/ijms20184472"},{"issue":"9","key":"4239_CR113","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","volume":"30","author":"J Kurreck","year":"2002","unstructured":"Kurreck J et al (2002) Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 30(9):1911\u20131918","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4239_CR114","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/0968-0896(96)00160-5","volume":"4","author":"D Yu","year":"1996","unstructured":"Yu D et al (1996) Hybrid oligonucleotides: synthesis, biophysical properties, stability studies, and biological activity. Bioorg Med Chem 4(10):1685\u20131692","journal-title":"Bioorg Med Chem"},{"issue":"19","key":"4239_CR115","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.1016\/S0021-9258(19)85268-7","volume":"268","author":"BP Monia","year":"1993","unstructured":"Monia BP et al (1993) Evaluation of 2\u2019-modified oligonucleotides containing 2\u2019-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268(19):14514\u201314522","journal-title":"J Biol Chem"},{"key":"4239_CR116","doi-asserted-by":"crossref","unstructured":"Crooke ST (2007) Antisense drug technology: principles, strategies, and applications, Second Edition. CRC","DOI":"10.1201\/9780849387951"},{"issue":"4","key":"4239_CR117","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","volume":"27","author":"ST Crooke","year":"2018","unstructured":"Crooke ST et al (2018) RNA-targeted therapeutics. Cell Metab 27(4):714\u2013739","journal-title":"Cell Metab"},{"issue":"9","key":"4239_CR118","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","volume":"25","author":"XH Liang","year":"2017","unstructured":"Liang XH et al (2017) RNase H1-Dependent antisense oligonucleotides are robustly active in directing RNA cleavage in both the cytoplasm and the Nucleus. Mol Ther 25(9):2075\u20132092","journal-title":"Mol Ther"},{"issue":"3","key":"4239_CR119","first-page":"194","volume":"24","author":"EE Neil","year":"2019","unstructured":"Neil EE, Bisaccia EK (2019) Nusinersen: a novel antisense oligonucleotide for the treatment of spinal muscular atrophy. J Pediatr Pharmacol Ther 24(3):194\u2013203","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"4239_CR120","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41593-020-0590-1","volume":"23","author":"CM Rodriguez","year":"2020","unstructured":"Rodriguez CM et al (2020) Prolonged survival. Nat Neurosci 23(3):386\u2013397","journal-title":"Nat Neurosci"},{"issue":"1","key":"4239_CR121","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41467-021-21021-w","volume":"12","author":"M Derbis","year":"2021","unstructured":"Derbis M et al (2021) Short antisense oligonucleotides alleviate the pleiotropic toxicity of RNA harboring expanded CGG repeats. Nat Commun 12(1):1265","journal-title":"Nat Commun"},{"issue":"4","key":"4239_CR122","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1021\/cb400875u","volume":"9","author":"T Tran","year":"2014","unstructured":"Tran T et al (2014) Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides. ACS Chem Biol 9(4):904\u2013912","journal-title":"ACS Chem Biol"},{"issue":"6","key":"4239_CR123","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/nat.2014.0506","volume":"24","author":"F Eckstein","year":"2014","unstructured":"Eckstein F (2014) Phosphorothioates, essential components of therapeutic oligonucleotides. Nucleic Acid Ther 24(6):374\u2013387","journal-title":"Nucleic Acid Ther"},{"issue":"7228","key":"4239_CR124","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature07758","volume":"457","author":"D Castanotto","year":"2009","unstructured":"Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457(7228):426\u2013433","journal-title":"Nature"},{"issue":"7092","key":"4239_CR125","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D et al (2006) Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441(7092):537\u2013541","journal-title":"Nature"},{"issue":"27","key":"4239_CR126","doi-asserted-by":"publisher","first-page":"17897","DOI":"10.1074\/jbc.R900012200","volume":"284","author":"AJ Pratt","year":"2009","unstructured":"Pratt AJ, MacRae IJ (2009) The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem 284(27):17897\u201317901","journal-title":"J Biol Chem"},{"key":"4239_CR127","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.omtn.2019.01.010","volume":"14","author":"R Martier","year":"2019","unstructured":"Martier R et al (2019) Artificial MicroRNAs Targeting C9orf72 can reduce Accumulation of intra-nuclear transcripts in ALS and FTD patients. Mol Ther Nucleic Acids 14:593\u2013608","journal-title":"Mol Ther Nucleic Acids"},{"key":"4239_CR128","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.001","volume":"16","author":"R Martier","year":"2019","unstructured":"Martier R et al (2019) Targeting RNA-Mediated toxicity in C9orf72 ALS and\/or FTD by RNAi-Based gene therapy. Mol Ther Nucleic Acids 16:26\u201337","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"4239_CR129","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/hmg\/ddr437","volume":"21","author":"H Tan","year":"2012","unstructured":"Tan H et al (2012) Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. Hum Mol Genet 21(1):57\u201365","journal-title":"Hum Mol Genet"},{"issue":"11","key":"4239_CR130","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/brain\/awab354","volume":"144","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) Therapeutic reversal of Huntington\u2019s disease by in vivo self-assembled siRNAs. Brain 144(11):3421\u20133435","journal-title":"Brain"},{"key":"4239_CR131","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.omtn.2019.09.018","volume":"18","author":"M Drozd","year":"2019","unstructured":"Drozd M et al (2019) Reduction of Fmr1 mRNA levels rescues pathological features in cortical neurons in a model of FXTAS. Mol Ther Nucleic Acids 18:546\u2013553","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"4239_CR132","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke ST et al (2021) Antisense technology: an overview and prospectus. Nat Rev Drug Discov 20(6):427\u2013453","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"4239_CR133","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","volume":"19","author":"EL Pfister","year":"2009","unstructured":"Pfister EL et al (2009) Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients. Curr Biol 19(9):774\u2013778","journal-title":"Curr Biol"},{"issue":"5","key":"4239_CR134","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18(5):358\u2013378","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"4239_CR135","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","volume":"29","author":"DA Amado","year":"2021","unstructured":"Amado DA, Davidson BL (2021) Gene therapy for ALS: a review. Mol Ther 29(12):3345\u20133358","journal-title":"Mol Ther"},{"key":"4239_CR136","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-017-0101-9","volume":"6","author":"S Aguiar","year":"2017","unstructured":"Aguiar S, van der Gaag B, Cortese FAB (2017) RNAi mechanisms in Huntington\u2019s disease therapy: siRNA versus shRNA. Transl Neurodegener 6:30","journal-title":"Transl Neurodegener"},{"issue":"Pt 4","key":"4239_CR137","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awr333","volume":"135","author":"R Grondin","year":"2012","unstructured":"Grondin R et al (2012) Six-month partial suppression of huntingtin is well tolerated in the adult rhesus striatum. Brain 135(Pt 4):1197\u20131209","journal-title":"Brain"},{"issue":"15","key":"4239_CR138","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL et al (2008) Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A 105(15):5868\u20135873","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4239_CR139","doi-asserted-by":"publisher","first-page":"655568","DOI":"10.3389\/fncel.2021.655568","volume":"15","author":"K Xu","year":"2021","unstructured":"Xu K et al (2021) Therapeutic development for CGG repeat expansion-Associated Neurodegeneration. Front Cell Neurosci 15:655568","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"4239_CR140","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","volume":"25","author":"AM Monteys","year":"2017","unstructured":"Monteys AM et al (2017) CRISPR\/Cas9 editing of the mutant huntingtin allele in Vitro and in vivo. Mol Ther 25(1):12\u201323","journal-title":"Mol Ther"},{"issue":"2","key":"4239_CR141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41551-020-00607-7","volume":"5","author":"R Batra","year":"2021","unstructured":"Batra R et al (2021) The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1. Nat Biomed Eng 5(2):157\u2013168","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"4239_CR142","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-022-00636-2","volume":"19","author":"M Chavez","year":"2023","unstructured":"Chavez M et al (2023) Advances in CRISPR therapeutics. Nat Rev Nephrol 19(1):9\u201322","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4239_CR143","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","volume":"172","author":"XS Liu","year":"2018","unstructured":"Liu XS et al (2018) Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell 172(5):979\u2013992e6","journal-title":"Cell"},{"key":"4239_CR144","doi-asserted-by":"crossref","unstructured":"Yrigollen CM, Davidson BL (2019) CRISPR to the rescue: advances in Gene Editing for the FMR1 gene. Brain Sci, 9(1)","DOI":"10.3390\/brainsci9010017"},{"issue":"10","key":"4239_CR145","doi-asserted-by":"publisher","first-page":"e0165499","DOI":"10.1371\/journal.pone.0165499","volume":"11","author":"N Xie","year":"2016","unstructured":"Xie N et al (2016) Reactivation of FMR1 by CRISPR\/Cas9-Mediated deletion of the expanded CGG-Repeat of the Fragile X chromosome. PLoS ONE 11(10):e0165499","journal-title":"PLoS ONE"},{"issue":"14","key":"4239_CR146","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1093\/nar\/gkab569","volume":"49","author":"L Poggi","year":"2021","unstructured":"Poggi L et al (2021) Differential efficacies of Cas nucleases on microsatellites involved in human disorders and associated off-target mutations. Nucleic Acids Res 49(14):8120\u20138134","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"4239_CR147","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF et al (2017) Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. BioDrugs 31(4):317\u2013334","journal-title":"BioDrugs"},{"issue":"1","key":"4239_CR148","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li T et al (2023) CRISPR\/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther 8(1):36","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"4239_CR149","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1039\/D2OB00279E","volume":"20","author":"H Murase","year":"2022","unstructured":"Murase H, Nagatsugi F, Sasaki S (2022) Development of a selective ligand for G-G mismatches of CGG repeat RNA inducing the RNA structural conversion from the G-quadruplex into a hairpin-like structure. Org Biomol Chem 20(16):3375\u20133381","journal-title":"Org Biomol Chem"},{"issue":"49","key":"4239_CR150","doi-asserted-by":"publisher","first-page":"18624","DOI":"10.1074\/jbc.RA119.009951","volume":"294","author":"KM Green","year":"2019","unstructured":"Green KM et al (2019) High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation. J Biol Chem 294(49):18624\u201318638","journal-title":"J Biol Chem"},{"issue":"19","key":"4239_CR151","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1021\/acschemneuro.3c00285","volume":"14","author":"C Sathyaseelan","year":"2023","unstructured":"Sathyaseelan C et al (2023) Destabilizing effect of Organo Ru(II) salts on the Intermolecular Parallel CGG Repeat DNA Quadruplex Associated with Neurodegenerative\/Neuromuscular diseases. ACS Chem Neurosci 14(19):3646\u20133654","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"4239_CR152","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/s41467-022-28653-6","volume":"13","author":"CG Keller","year":"2022","unstructured":"Keller CG et al (2022) An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion. Nat Commun 13(1):1150","journal-title":"Nat Commun"},{"issue":"16","key":"4239_CR153","doi-asserted-by":"publisher","first-page":"9479","DOI":"10.1093\/nar\/gkab669","volume":"49","author":"P Konieczny","year":"2021","unstructured":"Konieczny P et al (2021) Cyclic mismatch binding ligands interact with disease-associated CGG trinucleotide repeats in RNA and suppress their translation. Nucleic Acids Res 49(16):9479\u20139495","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4239_CR154","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1038\/s41598-021-87097-y","volume":"11","author":"Y Ajjugal","year":"2021","unstructured":"Ajjugal Y, Kolimi N, Rathinavelan T (2021) Secondary structural choice of DNA and RNA associated with CGG\/CCG trinucleotide repeat expansion rationalizes the RNA misprocessing in FXTAS. Sci Rep 11(1):8163","journal-title":"Sci Rep"},{"key":"4239_CR155","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.redox.2015.01.009","volume":"4","author":"N Gueven","year":"2015","unstructured":"Gueven N, Woolley K, Smith J (2015) Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10. Redox Biol 4:289\u2013295","journal-title":"Redox Biol"},{"key":"4239_CR156","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Rivero JM et al (2021) Coenzyme Q(10) analogues: benefits and challenges for therapeutics. Antioxid (Basel), 10(2)","DOI":"10.3390\/antiox10020236"},{"key":"4239_CR157","doi-asserted-by":"crossref","unstructured":"Clementi ME et al (2022) Cytoprotective Effect of Idebenone through Modulation of the intrinsic mitochondrial pathway of apoptosis in human retinal pigment epithelial cells exposed to oxidative stress Induced by Hydrogen Peroxide. Biomedicines, 10(2)","DOI":"10.3390\/biomedicines10020503"},{"issue":"2","key":"4239_CR158","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000381726","volume":"234","author":"N Arend","year":"2015","unstructured":"Arend N et al (2015) Idebenone prevents oxidative stress, cell death and senescence of Retinal Pigment Epithelium cells by stabilizing BAX\/Bcl-2 ratio. Ophthalmologica 234(2):73\u201382","journal-title":"Ophthalmologica"},{"issue":"1\u20132","key":"4239_CR159","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","volume":"47","author":"S Jaber","year":"2015","unstructured":"Jaber S, Polster BM (2015) Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr 47(1\u20132):111\u2013118","journal-title":"J Bioenerg Biomembr"},{"issue":"7","key":"4239_CR160","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s40265-016-0574-3","volume":"76","author":"KA Lyseng-Williamson","year":"2016","unstructured":"Lyseng-Williamson KA (2016) Idebenone: a review in Leber\u2019s Hereditary Optic Neuropathy. Drugs 76(7):805\u2013813","journal-title":"Drugs"},{"issue":"1","key":"4239_CR161","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13311-015-0409-z","volume":"13","author":"A Shirani","year":"2016","unstructured":"Shirani A, Okuda DT, St\u00fcve O (2016) Therapeutic advances and future prospects in Progressive forms of multiple sclerosis. Neurotherapeutics 13(1):58\u201369","journal-title":"Neurotherapeutics"},{"issue":"10","key":"4239_CR162","doi-asserted-by":"publisher","first-page":"e22876","DOI":"10.1002\/jbt.22876","volume":"35","author":"JX Jiang","year":"2021","unstructured":"Jiang JX et al (2021) Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice. J Biochem Mol Toxicol 35(10):e22876","journal-title":"J Biochem Mol Toxicol"},{"key":"4239_CR163","doi-asserted-by":"crossref","unstructured":"Santos E et al (2023) Open-label sulforaphane trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS). Cells, 12(24)","DOI":"10.3390\/cells12242773"},{"issue":"1","key":"4239_CR164","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/cr.2007.115","volume":"18","author":"GM Li","year":"2008","unstructured":"Li GM (2008) Mechanisms and functions of DNA mismatch repair. Cell Res 18(1):85\u201398","journal-title":"Cell Res"},{"key":"4239_CR165","doi-asserted-by":"crossref","unstructured":"Iyer RR, Pluciennik A (2021) DNA mismatch repair and its role in Huntington\u2019s disease J Huntingtons Dis, 10(1): pp. 75\u201394","DOI":"10.3233\/JHD-200438"},{"key":"4239_CR166","doi-asserted-by":"crossref","unstructured":"Richard GF (2021) The Startling Role of Mismatch Repair in Trinucleotide repeat expansions. Cells, 10(5)","DOI":"10.3390\/cells10051019"},{"key":"4239_CR167","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.dnarep.2015.11.008","volume":"38","author":"MHM Schmidt","year":"2016","unstructured":"Schmidt MHM, Pearson CE (2016) Disease-associated repeat instability and mismatch repair. DNA Repair (Amst) 38:117\u2013126","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"4239_CR168","doi-asserted-by":"publisher","first-page":"10419","DOI":"10.1038\/s41598-022-14183-0","volume":"12","author":"YH Hwang","year":"2022","unstructured":"Hwang YH et al (2022) Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation. Sci Rep 12(1):10419","journal-title":"Sci Rep"},{"key":"4239_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2018.07.001","volume":"69","author":"XN Zhao","year":"2018","unstructured":"Zhao XN, Usdin K (2018) FAN1 protects against repeat expansions in a fragile X mouse model. DNA Repair (Amst) 69:1\u20135","journal-title":"DNA Repair (Amst)"},{"key":"4239_CR170","doi-asserted-by":"crossref","unstructured":"Porro A et al (2021) FAN1-MLH1 interaction affects repair of DNA interstrand cross-links and slipped-CAG\/CTG repeats. Sci Adv, 7(31)","DOI":"10.1126\/sciadv.abf7906"},{"issue":"2","key":"4239_CR171","doi-asserted-by":"publisher","first-page":"109376","DOI":"10.1016\/j.celrep.2021.109376","volume":"36","author":"CR Singh","year":"2021","unstructured":"Singh CR et al (2021) Human oncoprotein 5MP suppresses general and repeat-associated non-AUG translation via eIF3 by a common mechanism. Cell Rep 36(2):109376","journal-title":"Cell Rep"},{"issue":"6","key":"4239_CR172","doi-asserted-by":"publisher","first-page":"118674","DOI":"10.1016\/j.bbamcr.2020.118674","volume":"1867","author":"MJ Wortman","year":"2020","unstructured":"Wortman MJ et al (2020) A synthetic pur-based peptide binds and alters G-quadruplex secondary structure present in the expanded RNA repeat of C9orf72 ALS\/FTD. Biochim Biophys Acta Mol Cell Res 1867(6):118674","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"2","key":"4239_CR173","doi-asserted-by":"publisher","first-page":"100914","DOI":"10.1016\/j.jbc.2021.100914","volume":"297","author":"YJ Tseng","year":"2021","unstructured":"Tseng YJ et al (2021) The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation. J Biol Chem 297(2):100914","journal-title":"J Biol Chem"},{"issue":"1","key":"4239_CR174","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1038\/s41467-020-19505-2","volume":"11","author":"K Bulaklak","year":"2020","unstructured":"Bulaklak K, Gersbach CA (2020) The once and future gene therapy. Nat Commun 11(1):5820","journal-title":"Nat Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04239-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04239-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04239-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T14:18:07Z","timestamp":1732285087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04239-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":174,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4239"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04239-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}